Toxicological effects of ciprofloxacin and chlorhexidine on growth and chlorophyll a synthesis of freshwater cyanobacteria

Detalhes bibliográficos
Autor(a) principal: Azevedo, Fernanda Cristina Rezende
Data de Publicação: 2019
Outros Autores: Vaz, Izabela Cristina Dias, Barbosa, Francisco Antônio Rodrigues, Magalhães, Sérgia Maria Starling
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/180954
Resumo: Cyanobacteria are phytoplanktonic microorganisms that are susceptible to the deleterious effects of pharmaceutical residues in the aquatic environment, which poses a challenge to the environment exposed to diverse pharmaceutical products and their potential effects. The objective of this study was to evaluate the effects of the antibiotic substances ciprofloxacin and chlorhexidine in pharmaceutical preparations on the growth and production of chlorophyll of two cyanobacterial strains, Microcystis aeruginosa and Microcystis panniformis, isolated from a lake in a Brazilian environmental protection area. The EC50 and EC10 of chlorhexidine for M. aeruginosa were 206.4 μg/L and 108.5 μg/L, respectively, and for M. panniformis were 171.4 μg/L and 116.6 μg/L, respectively. The EC50 and EC10 of ciprofloxacin for M. aeruginosa were 17.24 μg/L and 3.21 μg/L, respectively, and for M. panniformis were 13.56 μg/L and 1.50 μg/L, respectively. The toxicity of the antibiotic ciprofloxacin (drug) and chlorhexidine (standard solution) to the Microcystis species was demonstrated, and these species were both very sensitive to ciprofloxacin. Our results suggest that the strains of M. aeruginosa and M. panniformis may be affected by exposure to residues of ciprofloxacin (>1.5 μg/L), which may represent a risk to the survival of aquatic species.
id USP-31_3c9ad9d6a368e85b82b95d4bae85d428
oai_identifier_str oai:revistas.usp.br:article/180954
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Toxicological effects of ciprofloxacin and chlorhexidine on growth and chlorophyll a synthesis of freshwater cyanobacteriaEcotoxicological testAntibioticsAntisepticContaminants of emerging interestGrowth inhibitionCyanobacteria are phytoplanktonic microorganisms that are susceptible to the deleterious effects of pharmaceutical residues in the aquatic environment, which poses a challenge to the environment exposed to diverse pharmaceutical products and their potential effects. The objective of this study was to evaluate the effects of the antibiotic substances ciprofloxacin and chlorhexidine in pharmaceutical preparations on the growth and production of chlorophyll of two cyanobacterial strains, Microcystis aeruginosa and Microcystis panniformis, isolated from a lake in a Brazilian environmental protection area. The EC50 and EC10 of chlorhexidine for M. aeruginosa were 206.4 μg/L and 108.5 μg/L, respectively, and for M. panniformis were 171.4 μg/L and 116.6 μg/L, respectively. The EC50 and EC10 of ciprofloxacin for M. aeruginosa were 17.24 μg/L and 3.21 μg/L, respectively, and for M. panniformis were 13.56 μg/L and 1.50 μg/L, respectively. The toxicity of the antibiotic ciprofloxacin (drug) and chlorhexidine (standard solution) to the Microcystis species was demonstrated, and these species were both very sensitive to ciprofloxacin. Our results suggest that the strains of M. aeruginosa and M. panniformis may be affected by exposure to residues of ciprofloxacin (>1.5 μg/L), which may represent a risk to the survival of aquatic species.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2019-12-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/18095410.1590/s2175-97902019000217661Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e17661 Brazilian Journal of Pharmaceutical Sciences; v. 55 (2019); e17661 Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e17661 2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/180954/167977Copyright (c) 2019 Brazilian Journal of Pharmaceutical Scienceshttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessAzevedo, Fernanda Cristina Rezende Vaz, Izabela Cristina Dias Barbosa, Francisco Antônio Rodrigues Magalhães, Sérgia Maria Starling 2021-01-19T16:47:29Zoai:revistas.usp.br:article/180954Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2021-01-19T16:47:29Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Toxicological effects of ciprofloxacin and chlorhexidine on growth and chlorophyll a synthesis of freshwater cyanobacteria
title Toxicological effects of ciprofloxacin and chlorhexidine on growth and chlorophyll a synthesis of freshwater cyanobacteria
spellingShingle Toxicological effects of ciprofloxacin and chlorhexidine on growth and chlorophyll a synthesis of freshwater cyanobacteria
Azevedo, Fernanda Cristina Rezende
Ecotoxicological test
Antibiotics
Antiseptic
Contaminants of emerging interest
Growth inhibition
title_short Toxicological effects of ciprofloxacin and chlorhexidine on growth and chlorophyll a synthesis of freshwater cyanobacteria
title_full Toxicological effects of ciprofloxacin and chlorhexidine on growth and chlorophyll a synthesis of freshwater cyanobacteria
title_fullStr Toxicological effects of ciprofloxacin and chlorhexidine on growth and chlorophyll a synthesis of freshwater cyanobacteria
title_full_unstemmed Toxicological effects of ciprofloxacin and chlorhexidine on growth and chlorophyll a synthesis of freshwater cyanobacteria
title_sort Toxicological effects of ciprofloxacin and chlorhexidine on growth and chlorophyll a synthesis of freshwater cyanobacteria
author Azevedo, Fernanda Cristina Rezende
author_facet Azevedo, Fernanda Cristina Rezende
Vaz, Izabela Cristina Dias
Barbosa, Francisco Antônio Rodrigues
Magalhães, Sérgia Maria Starling
author_role author
author2 Vaz, Izabela Cristina Dias
Barbosa, Francisco Antônio Rodrigues
Magalhães, Sérgia Maria Starling
author2_role author
author
author
dc.contributor.author.fl_str_mv Azevedo, Fernanda Cristina Rezende
Vaz, Izabela Cristina Dias
Barbosa, Francisco Antônio Rodrigues
Magalhães, Sérgia Maria Starling
dc.subject.por.fl_str_mv Ecotoxicological test
Antibiotics
Antiseptic
Contaminants of emerging interest
Growth inhibition
topic Ecotoxicological test
Antibiotics
Antiseptic
Contaminants of emerging interest
Growth inhibition
description Cyanobacteria are phytoplanktonic microorganisms that are susceptible to the deleterious effects of pharmaceutical residues in the aquatic environment, which poses a challenge to the environment exposed to diverse pharmaceutical products and their potential effects. The objective of this study was to evaluate the effects of the antibiotic substances ciprofloxacin and chlorhexidine in pharmaceutical preparations on the growth and production of chlorophyll of two cyanobacterial strains, Microcystis aeruginosa and Microcystis panniformis, isolated from a lake in a Brazilian environmental protection area. The EC50 and EC10 of chlorhexidine for M. aeruginosa were 206.4 μg/L and 108.5 μg/L, respectively, and for M. panniformis were 171.4 μg/L and 116.6 μg/L, respectively. The EC50 and EC10 of ciprofloxacin for M. aeruginosa were 17.24 μg/L and 3.21 μg/L, respectively, and for M. panniformis were 13.56 μg/L and 1.50 μg/L, respectively. The toxicity of the antibiotic ciprofloxacin (drug) and chlorhexidine (standard solution) to the Microcystis species was demonstrated, and these species were both very sensitive to ciprofloxacin. Our results suggest that the strains of M. aeruginosa and M. panniformis may be affected by exposure to residues of ciprofloxacin (>1.5 μg/L), which may represent a risk to the survival of aquatic species.
publishDate 2019
dc.date.none.fl_str_mv 2019-12-09
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/180954
10.1590/s2175-97902019000217661
url https://www.revistas.usp.br/bjps/article/view/180954
identifier_str_mv 10.1590/s2175-97902019000217661
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/180954/167977
dc.rights.driver.fl_str_mv Copyright (c) 2019 Brazilian Journal of Pharmaceutical Sciences
http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2019 Brazilian Journal of Pharmaceutical Sciences
http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e17661
Brazilian Journal of Pharmaceutical Sciences; v. 55 (2019); e17661
Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e17661
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222914562228224